171 related articles for article (PubMed ID: 31759898)
1. Plasma exchange as treatment for osmotic demyelination syndrome: Case report and review of current literature.
Nelson NR; Tompkins MG; Thompson Bastin ML
Transfus Apher Sci; 2019 Dec; 58(6):102663. PubMed ID: 31759898
[TBL] [Abstract][Full Text] [Related]
2. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.
Lohr JW
Am J Med; 1994 May; 96(5):408-13. PubMed ID: 8192171
[TBL] [Abstract][Full Text] [Related]
3. The Improvement of the Outcome of Osmotic Demyelination Syndrome by Plasma Exchange.
Kumon S; Usui R; Kuzuhara S; Nitta K; Koike M
Intern Med; 2017; 56(6):733-736. PubMed ID: 28321080
[TBL] [Abstract][Full Text] [Related]
4. Osmotic demyelination syndrome after correction of severe hyponatremia associated with pituitrin.
Xu DH; Yuan M; Wang JW; Hu YZ
Int J Clin Pharmacol Ther; 2015 May; 53(5):408-11. PubMed ID: 25740269
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction.
Gayathri DK; Dhayalen K; Chia YK; Fung YK
Med J Malaysia; 2019 Aug; 74(4):331-332. PubMed ID: 31424043
[TBL] [Abstract][Full Text] [Related]
6. Osmotic demyelination syndrome following acute kidney injury with hypernatremia.
Alkali NH; Jibrin YB; Dunga JA; Abdu A
Niger J Clin Pract; 2019 Aug; 22(8):1166-1168. PubMed ID: 31417063
[TBL] [Abstract][Full Text] [Related]
7. Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤10 mEq/L per Day.
Tandukar S; Sterns RH; Rondon-Berrios H
Kidney360; 2021 Sep; 2(9):1415-1423. PubMed ID: 35373113
[TBL] [Abstract][Full Text] [Related]
8. Minocycline prevents osmotic demyelination associated with aquaresis.
Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
[TBL] [Abstract][Full Text] [Related]
9. Azotemia protects the brain from osmotic demyelination on rapid correction of hyponatremia.
Dhrolia MF; Akhtar SF; Ahmed E; Naqvi A; Rizvi A
Saudi J Kidney Dis Transpl; 2014 May; 25(3):558-66. PubMed ID: 24821152
[TBL] [Abstract][Full Text] [Related]
10. Osmotic demyelination syndrome in patients with non-Hodgkin lymphoma: a case report and literature review.
García-Grimshaw M; Jiménez-Ruiz A; Ruiz-Sandoval JL; Cantú-Brito C; Chiquete E
Int J Neurosci; 2023 Mar; 133(3):233-237. PubMed ID: 33765889
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic challenges in the management of osmotic demyelination syndrome: A case report of a favorable outcome from a tertiary center.
Elshafei M; Danjuma MI; Tahir RE
Medicine (Baltimore); 2020 Jun; 99(24):e20283. PubMed ID: 32541452
[TBL] [Abstract][Full Text] [Related]
12. [Osmotic demyelination syndrome in patients with hyponatremia caused by neurologic disorders].
Jiang Y; Wei JJ; Wang RZ; Ren ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Dec; 33(6):696-700. PubMed ID: 22509558
[TBL] [Abstract][Full Text] [Related]
13. Osmotic demyelination syndrome improving after immune-modulating treatment: Case report and literature review.
Kalampokini S; Artemiadis A; Zis P; Hadjihannas L; Parpas G; Kyrri A; Hadjigeorgiou GM
Clin Neurol Neurosurg; 2021 Sep; 208():106811. PubMed ID: 34358802
[TBL] [Abstract][Full Text] [Related]
14. Osmotic Demyelination Syndrome Following Hyponatremia-Oriented Management in Liver Transplant: A Single Center 20-Year Experience.
Park M; Son HJ; Kim GS
Exp Clin Transplant; 2019 Aug; 17(4):540-545. PubMed ID: 31104624
[TBL] [Abstract][Full Text] [Related]
15. Incremental increases in glucocorticoid doses may reduce the risk of osmotic demyelination syndrome in a patient with hyponatremia due to central adrenal insufficiency.
Yoshioka K; Minami M; Fujimoto S; Yamaguchi S; Adachi K; Yamagami K
Intern Med; 2012; 51(9):1069-72. PubMed ID: 22576389
[TBL] [Abstract][Full Text] [Related]
16. Isolated extrapontine myelinolysis of osmotic demyelination syndrome.
Yilmaz O; Armagn HH; Turan A; Duymuş M
Prague Med Rep; 2013; 114(1):35-8. PubMed ID: 23547724
[TBL] [Abstract][Full Text] [Related]
17. Osmotic demyelination syndrome.
King JD; Rosner MH
Am J Med Sci; 2010 Jun; 339(6):561-7. PubMed ID: 20453633
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of osmotic demyelination syndrome with plasmapheresis: a case report and review of the literature.
Wijayabandara M; Appuhamy S; Weerathunga P; Chang T
J Med Case Rep; 2021 Jan; 15(1):6. PubMed ID: 33430956
[TBL] [Abstract][Full Text] [Related]
19. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome.
Iwama S; Sugimura Y; Suzuki H; Suzuki H; Murase T; Ozaki N; Nagasaki H; Arima H; Murata Y; Sawada M; Oiso Y
Glia; 2011 Mar; 59(3):452-62. PubMed ID: 21264951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
